Effective and safe pharmacotherapy of recurrent bronchitis in children of different ages and prevention of its chronicization is important. More than 100 million cases of bronchopulmonary diseases among children are registered worldwide. Of all pathological conditions, today respiratory diseases account for more than 50% of the total morbidity in children of different ages. A high increase in bronchopulmonary diseases is observed especially among children of preschool and school age, and improper management and self-medication of such patients can subsequently lead to a protracted and recurrent course of the pathological process, which acquires medical and social significance. Recurrent bronchitis is characterized by repeated episodes of acute bronchitis 2-3 times or more during the year against the background of an acute respiratory infection. The criteria for diagnosing an acute episode correspond to the clinical and radiological signs of acute bronchitis – clinical data: increased body temperature, dry cough, sometimes wet, diffuse dry and variable moist rales in the lungs; X-ray picture: change in the pulmonary pattern without infiltrative and focal shadows in the lungs.
